Sort   by:  
 Page size 
ProteomicsFunctional proteomics defines a PRC2-G9A interaction network and reveals ZNF518B as a G9A regulator
Not available
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2014-12-17 | MSV000078980 | MassIVE
ProteomicsComparative analysis of the secretome from a model filarial nematode (Litomosoides sigmodontis) reveals maximal diversity in gravid female parasites
Filarial nematodes (superfamily Filarioidea) are responsible for an annual global health burden of approximately 6.3 million disability-adjusted life-years, which represents the greatest single component of morbidity attributable to helminths affecting humans. No vaccine exists for the major filaria...
ORGANISM(S): Litomosoides sigmodontis (Filarial nematode worm) 
2014-07-22 | PXD000756 | Pride
Filarial nematode Excretory-secretory products Lc-ms/ms Litomosoides sigmodontis 
UnknownThe attribution of human health outcomes to climate change: a transdisciplinary guidance document.
Not available
S-EPMC7618133 | biostudies-literature
UnknownLarge-scale and long-term wildlife research and monitoring using camera traps: a continental synthesis.
Not available
S-EPMC11885691 | biostudies-literature
UnknownDifferential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study.
Not available
S-EPMC7486122 | biostudies-literature
UnknownActive symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial.
Not available
S-EPMC2431123 | biostudies-literature
UnknownEffect of Aspirin on Disability-free Survival in the Healthy Elderly.
Not available
S-EPMC6426126 | biostudies-literature
UnknownEffect of Aspirin on All-Cause Mortality in the Healthy Elderly.
Not available
S-EPMC6433466 | biostudies-literature
UnknownA core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials.
Not available
S-EPMC12568921 | biostudies-literature
UnknownSafety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Not available
S-EPMC7674972 | biostudies-literature
Sort   by:  
 Page size